Antiretroviral therapy has revolutionized the course of HIV infection, improving immune
function and decreasing dramatically the mortality and morbidity due to the opportunistic …

Tenofovir and bone health : Current Opinion in HIV and AIDS Tenofovir and bone health :
Current Opinion in HIV and AIDS Log in or Register Subscribe to journalSubscribe Get new …

Abstract Background. Daily preexposure prophylaxis (PrEP) with oral emtricitabine and
tenofovir disoproxil fumarate (FTC/TDF) decreases the risk of human immunodeficiency …

Objective (s): Some but not all studies indicate that individuals with HIV infection are at an
increased risk of fracture. We systematically reviewed the literature to investigate whether …

Linkage and retention in care soon after HIV diagnosis improves clinical outcomes.
Conversely, missed visits after diagnosis are associated with increased mortality in the …

Background: We previously reported that fracture incidence rates did not differ by HIV status
among predominantly premenopausal Women's Interagency HIV Study participants. We …

Increased life expectancy due to improved efficacy of cART has uncovered an increased risk
of age-related morbidities in HIV+ individuals and catalyzed significant research into …

Objectives: To determine the incidence of fracture among aging HIV-infected (HIV+) and
uninfected men (HIV−). To evaluate factors independently associated with fracture risk …

Opinion Statement There are 34 studies in almost 2 million participants that have reported
on the association between proton pump inhibitor (PPI) therapy and risk of fracture. There is …

PLHIV have an increased risk of osteoporosis and fractures when compared with people of
the same age and sex. In this review, we address the epidemiology and the pathophysiology …